Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada · Delayed Price · Currency is CAD 7.35
-0.22 (-2.91%)
Sep 12, 2025, 3:59 PM EDT
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of CAD 264.30 million as of September 12, 2025. Its market cap has increased by 107.25% in one year.
Market Cap
264.30M
Enterprise Value
278.48M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
7.35
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from 78.01M to 264.30M, an increase of 238.82%. That is a compound annual growth rate of 31.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 264.30M | 64.51% |
| Dec 31, 2024 | 160.66M | 9.74% |
| Dec 29, 2023 | 146.40M | 85.76% |
| Dec 30, 2022 | 78.81M | 125.87% |
| Dec 31, 2021 | 34.89M | -55.27% |
| Mar 9, 2021 | 78.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.55B |
| Green Thumb Industries | 2.38B |
| Trulieve Cannabis | 1.83B |
| Sienna Senior Living | 1.69B |
| dentalcorp Holdings | 1.63B |
| Cronos Group | 1.34B |
| WELL Health Technologies | 1.19B |
| Extendicare | 1.11B |